The Wall Street Journal - January 11, 2022
Nir Barzilai, M.D., talks about plans for a clinical trial to study metformin, a diabetes drug, as an anti-aging medicine that may delay the onset of cardiovascular disease, dementia, and other age-related diseases. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Medscape - January 10, 2022
Kartik Chandran, Ph.D., and Denise Haslwanter, Ph.D., describe their study that finds the human antibody response induced by the widely used yellow fever vaccine has reduced activity against the recent Brazilian strain of the virus. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology at Einstein. Dr. Haslwanter is a research fellow in Dr. Chandran's lab.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
The New York Times - January 8, 2022
In a letter to the editor, written in response to a story about false positives in prenatal genetic testing, Susan Klugman, M.D., explains that these tests, like mammography, are for screening, not diagnosis, and that healthcare practitioners with appropriate training must provide genetic counseling to parents prior to testing. Dr. Klugman is professor of pediatrics and of obstetrics & gynecology and women's health at Einstein, and director of reproductive and medical genetics at Montefiore.
Dr. Klugman's ProfileMore coverage on Dr. Klugman
US News & World Report - January 6, 2022
Richard Lipton, M.D., comments on a study highlighting the connection between heart and brain health, particularly in women. Dr. Lipton is professor in the Saul R. Korey Department of Neurology, of psychiatry and behavioral sciences, and of epidemiology & population health and holds the Edwin S. Lowe Professor at Einstein, and is vice chair of neurology at Einstein and Montefiore.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
The Washington Post - December 21, 2021
Liise-anne Pirofski, M.D., says the Federal Drug Administration should expand the use of convalescent plasma to outpatient use to help fight COVID-19, particularly during the current surge of the omicron variant. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Selma and Dr. Jacques Mitrani Chair in Biomedical Research at Einstein.
Additional coverage includes: The Scientist
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski
Science News - December 21, 2021
Kartik Chandran, Ph.D., says the omicron variant of the coronavirus that causes COVID-19 may be both more transmissible and better able to evade the immune response than previous variants, although more data is needed. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
NBC News - December 20, 2021
Frederick Kaskel, M.D., Ph.D., and third-year Einstein medical student John McCarthy discuss their review paper in JAMA Pediatrics about the long-lasting effects of the 1918 influenza pandemic on children whose mothers were pregnant with them at that time. Dr. Kaskel is professor of pediatrics at Einstein and chief emeritus, division of pediatric nephrology at Einstein and Children's Hospital at Montefiore.
Dr. Kaskel's Profile
UPI - December 13, 2021
Liise-anne Pirofski, M.D., comments on her study, co-led with Hyunah Yoon, M.D., and collaborators at NYU Langone and other academic medical centers, that suggests convalescent plasma may be a safe and readily available treatment option for certain patients at the beginning of a pandemic wave when other therapies are not yet available. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Dr. Jacques Mitrani Chair in Biomedical Research at Einstein. Dr. Yoon is assistant professor of medicine at Einstein and an attending physician at Montefiore.
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski
STAT News - December 6, 2021
Michael Lipton, M.D., Ph.D., and June Ng, M.D., comment on the lack of data about possible side effects of hormonal contraception. Dr. Lipton is professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein, and director of MRI Services at Montefiore. Dr. Ng is a fellow in complex family planning and a clinical instructor in obstetrics, gynecology, and women's health at Einstein and Montefiore.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
KNX In Depth - November 29, 2021
Kartik Chandran, Ph.D., says there is much to learn about the new COVID-19 variant, omicron, including if it is more likely to cause severe disease or spread more easily that currently dominant variants. He notes the importance of vaccination and getting booster shots to protect against the virus. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein. (Interview begins at 1:22)
Dr. Chandran's ProfileMore coverage on Dr. Chandran
CBS News - November 28, 2021
Nir Barzilai, M.D., talks about his plans for a clinical trial to study metformin, a diabetes drug, to target age-related diseases and to extend both lifespan and health span. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore. (Interview begins at 2:45)
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Medscape - November 23, 2021
Lauren Shapiro, M.D., and Astha Thakkar, M.B.B.S., discuss their study that found that most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 developed antibodies following a booster shot. Drs. Shapiro and Thakkar are third-year hematology/oncology fellows at Albert Einstein College of Medicine and Montefiore Medical Center.
Additional Coverage includes UPI, U.S. News & World Report (via HealthDay), MedPage Today
Popular Science - November 22, 2021
Michael Aschner, Ph.D., comments on a study that found high concentrations of mercury in ancient bones from Iberia, which researchers believe was caused by exposure to the toxic red pigment made from cinnabar rock. Dr. Aschner is professor of molecular pharmacology, in the Dominick P. Purpura Department of Neuroscience, and of pediatrics, and is the Harold & Muriel Block Chair in Molecular Pharmacology.
Dr. Aschner's Profile
STAT News - November 22, 2021
Joanna Starrels, M.D., M.S., explains that awareness is increasing among providers that there are risks associated with suddenly or significantly reducing a patient's opioid dose. She notes, however, that research is needed to identify and appropriately treat those at high risk for withdrawal symptoms, increased pain, serious psychological distress, and suicidal thoughts. Dr. Starrels is associate professor of medicine at Einstein and an internist and addiction medicine specialist at Montefiore.
Dr. Starrels' ProfileMore coverage on Dr. Starrels
Review of Ophthamology - October 10, 2021
Roy Chuck, M.D., Ph.D., describes the benefits of a new contact lens-like device, patented by Montefiore and Einstein, that is used in a treatment for keratoconus, an eye disease that affects the structure of the cornea. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
Nature - September 2, 2020
In a commentary for Nature, Gary Schwartz, Ph.D., writes about the discovery of a pathway in the preoptic area of the brain in mice by which a light-sensitive protein regulates heat production. The findings may lead to ways of altering metabolism by manipulating environmental light. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons